Icosavax, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Icosavax, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2022.
  • Icosavax, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $36.4M, a 77.1% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $36.4M +$15.8M +77.1% Dec 31, 2022 10-K 2023-03-30
Q4 2021 $20.5M +$14.5M +238% Dec 31, 2021 10-K 2023-03-30
Q4 2020 $6.08M Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.